ClinicalTrials.gov
ClinicalTrials.gov Menu

PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00303290
Recruitment Status : Completed
First Posted : March 16, 2006
Last Update Posted : November 26, 2015
Sponsor:
Collaborator:
Schering-Plough
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2014
  Actual Study Completion Date : November 2014